Humana Inc. Files 8-K for Regulation FD Disclosure
Ticker: HUM · Form: 8-K · Filed: Aug 29, 2025 · CIK: 49071
| Field | Detail |
|---|---|
| Company | Humana Inc (HUM) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $13.77, $17.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
Related Tickers: HUM
TL;DR
Humana filed an 8-K today for a Reg FD disclosure. Details TBD.
AI Summary
On August 29, 2025, Humana Inc. filed a Form 8-K to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report filed on the specified date.
Why It Matters
This filing indicates Humana Inc. is making a public disclosure under Regulation FD, which ensures all investors receive important information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard regulatory disclosure and does not inherently present new risks.
Key Players & Entities
- Humana Inc. (company) — Registrant
- August 29, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
FAQ
What specific information is being disclosed under Regulation FD by Humana Inc.?
The provided filing excerpt does not specify the content of the Regulation FD disclosure, only that one was made on August 29, 2025.
What is the significance of a Form 8-K filing for Regulation FD?
A Form 8-K filing for Regulation FD ensures that material non-public information is disclosed to the public in a timely and non-discriminatory manner.
When was this Form 8-K filed by Humana Inc.?
The Form 8-K was filed on August 29, 2025.
What is Humana Inc.'s principal executive office address?
Humana Inc.'s principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202.
What is Humana Inc.'s IRS Employer Identification Number?
Humana Inc.'s IRS Employer Identification Number is 61-0647538.
Filing Stats: 793 words · 3 min read · ~3 pages · Grade level 13.3 · Accepted 2025-08-29 16:30:11
Key Financial Figures
- $13.77 — reaffirm its guidance of approximately $13.77 in diluted earnings per common share ("
- $17.00 — r common share ("EPS") or approximately $17.00 in adjusted earnings per common share (
Filing Documents
- hum-20250829.htm (8-K) — 33KB
- 0000049071-25-000044.txt ( ) — 146KB
- hum-20250829.xsd (EX-101.SCH) — 2KB
- hum-20250829_lab.xml (EX-101.LAB) — 21KB
- hum-20250829_pre.xml (EX-101.PRE) — 12KB
- hum-20250829_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Members of Humana Inc.'s (the "Company") senior management team are scheduled to meet with investors and analysts at various meetings between September 1, 2025 and September 30, 2025. During these meetings, the Company intends to reaffirm its guidance of approximately $13.77 in diluted earnings per common share ("EPS") or approximately $17.00 in adjusted earnings per common share ("Adjusted EPS"), in each case for the year ending December 31, 2025 ("FY 2025"). This guidance is consistent with the guidance issued in the Company's press release dated July 30, 2025. As indicated on the Company's second quarter 2025 earnings call on July 30, 2025, the Company will not be commenting on 2026 Medicare Advantage (MA) Star Ratings (Bonus Year 2027) until the Centers for Medicare and Medicaid Services (CMS) releases final 2026 MA Star Ratings data in October. The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles ("GAAP"). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company's core operating performance over time. Consequently, management uses Adjusted EPS as a consistent and uniform indicator of the Company's core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows: Diluted earnings per common share FY 2025 Guidance GAAP Approximately $13.77 Amortization of identifiable intangibles 0.49 Put/call valuation adjustments associated with the Company's non-consolidating minority interest investments (a) 3.01 Value creation initiatives (a) 0.44 Im
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. HUMANA INC. BY: /s/ John-Paul W. Felter John-Paul W. Felter Senior Vice President, Chief Accounting Officer & Controller (Principal Accounting Officer) Dated: August 29, 2025